Up to now, the measurement of carbohydrate-deficient transferrin (CDT) has been used in persons with a regular alcohol consumption of > 60 g/day, primarily due to aspects of insurance medicine, as its levels have an informative value even at 2 to 3 weeks after the discontinuation of consumption. Objective: There is scarce information in the literature concerning CDT levels in individuals who used chemicals, and therefore we think our cases deserve interest. Case Report: In the first case the measurement was performed at 1 month after the use of a nitro-based varnish, and the CDT value was elevated. In the other case the examination was performed in an agricultural worker who had used chemical weed-killers regularly but discontinued it 6 months before. He also had a very high CDT value. Conclusion: As both workers were documented abstainers, the CDT elevation might be due to the exposition to chemicals. The authors consider these high CDT values as markers of an injury caused by exposition to chemicals.
Stibler, H., Allgulander, C., Borg, K. G. et al.: Abnormal micro-heterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism. Acta Med. Scand., 1978, 204 , 49–56.
Borg K. G. , 'Abnormal micro-heterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism ' (1978 ) 204 Acta Med. Scand. : 49 -56 .
Arndt, T.: Carbohydrate deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretetion. Clin. Chem., 2001, 47 , 13–27.
Arndt T. , 'Carbohydrate deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretetion ' (2001 ) 47 Clin. Chem. : 13 -27 .
Chrostek, L., Cylwik, B., Szmikowski, M. et al.: The diagnostic accuracy of carbohydrate deficient transferrin, sialic acid and commonly used markers of alcohol abuse during abstinence. Clin. Chim. Acta, 2006, 364 , 167–171.
Szmikowski M. , 'The diagnostic accuracy of carbohydrate deficient transferrin, sialic acid and commonly used markers of alcohol abuse during abstinence ' (2006 ) 364 Clin. Chim. Acta : 167 -171 .
Golka, K., Sondermann, R., Reich, S. E. et al.: Carbohydrate-deficient transferrin (CDT) as a biomarker in persons suspected of alcohol abuse. Toxicol. Lett., 2004, 151 , 235–241.
Reich S. E. , 'Carbohydrate-deficient transferrin (CDT) as a biomarker in persons suspected of alcohol abuse ' (2004 ) 151 Toxicol. Lett. : 235 -241 .
Fehér, J., Lengyel, G., Szabó, Gy.: Carbohydrate-Deficient Transferrin as a Marker of Alcohol Consumption. Hung. Med. J., 2007, 1 , 73–82.
Szabó Gy. , 'Carbohydrate-Deficient Transferrin as a Marker of Alcohol Consumption ' (2007 ) 1 Hung. Med. J. : 73 -82 .
Schäper, M., Demes, P., Kiesswetter, E. et al.: Colourvision and occupational toluine exposure result of repeated examinations. Toxicol. Lett., 2004, 15 , 193–202.
Kiesswetter E. , 'Colourvision and occupational toluine exposure result of repeated examinations ' (2004 ) 15 Toxicol. Lett. : 193 -202 .
Arndt, T., Keller, T.: Forensic analysis of carbohydrate-deficient transferrin (CDT): implementation of a screening and confirmatory analysis concept is hampered by the lack of CDT isoform standards. Forensic Sci. Int., 2004, 46 , 9–16.
Keller T. , 'Forensic analysis of carbohydrate-deficient transferrin (CDT): implementation of a screening and confirmatory analysis concept is hampered by the lack of CDT isoform standards ' (2004 ) 46 Forensic Sci. Int. : 9 -16 .
Bilban, M., Vrhovec, S., Karlovsek, M. Z.: Blood biomarkers of alcohol abuse. Arh. Hig. Rada Toksikol., 2003, 54 , 253–259.
Karlovsek M. Z. , 'Blood biomarkers of alcohol abuse ' (2003 ) 54 Arh. Hig. Rada Toksikol. : 253 -259 .
Pérez-Cerdá, C., Quelhas, D., Vega, A. I. et al.: Screening using serum percentage of carbohydrate-deficient transferrin for congenital disorders of glycosylation in children with suspected metabolic disease. Clin. Chem., 2008, 54 , 93–100. Epub 2007 Nov 16.
Vega A. I. , 'Screening using serum percentage of carbohydrate-deficient transferrin for congenital disorders of glycosylation in children with suspected metabolic disease ' (2008 ) 54 Clin. Chem. : 93 -100 .
Anton, R. F., Youngblood, M.: Factors affecting %CDT status at entry into a multisite clinical treatment trial: experience from the COMBINE Study. Alcohol Clin. Exp. Res., 2006, 11 , 1878–1883.
Youngblood M. , 'Factors affecting %CDT status at entry into a multisite clinical treatment trial: experience from the COMBINE Study ' (2006 ) 11 Alcohol Clin. Exp. Res. : 1878 -1883 .
Biffi, S., Tamaro, G., Bortot, B. et al.: Carbohydrate-deficient transferrin (CDT) as a biochemical tool for the screening of congenital disorders of glycosylation (CDGs). Clin. Biochem., 2007, 40 , 1431–1434.
Bortot B. , 'Carbohydrate-deficient transferrin (CDT) as a biochemical tool for the screening of congenital disorders of glycosylation (CDGs) ' (2007 ) 40 Clin. Biochem. : 1431 -1434 .
Bergström, J. P., Helander, A.: Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: Implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker. Clin. Chim. Acta, 2008, 388 , 59–67.
Helander A. , 'Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: Implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker ' (2008 ) 388 Clin. Chim. Acta : 59 -67 .
Stibler, H., Borg, S., Joustra, M.: Micro anion exchange chromatography of carbohydrate deficient transferrin in serum inrelation to alcohol consumption (Swedish Patent 8400587-5). Alcohol Clin. Exp. Res., 1986, 10 , 535–544.
Joustra M. , 'Micro anion exchange chromatography of carbohydrate deficient transferrin in serum inrelation to alcohol consumption (Swedish Patent 8400587-5) ' (1986 ) 10 Alcohol Clin. Exp. Res. : 535 -544 .
Myrick, H., Henderson, S., Anton, R. F.: Utility of a new assay for carbohydrate-deficient transferrin (BIORAD %CDT TIA) to monitor abstinence during treatment outcome study. Alcohol Clin. Exp. Res., 2001, 25 , 1330–1334.
Anton R. F. , 'Utility of a new assay for carbohydrate-deficient transferrin (BIORAD %CDT TIA) to monitor abstinence during treatment outcome study ' (2001 ) 25 Alcohol Clin. Exp. Res. : 1330 -1334 .
Szabó, Gy., Környei, L., Keller, É. et al.: The level of carbohydrate deficient transferrin in the Hungarian population according to gender and age. (In Hungarian). Orv. Hetil., 2007, 148 , 1409–1413.
Keller É. , 'The level of carbohydrate deficient transferrin in the Hungarian population according to gender and age (In Hungarian) ' (2007 ) 148 Orv. Hetil. : 1409 -1413 .
Jakab, L.: The pathophysiological significance of carbohydrate deficient transferrin. (In Hungarian). Orv. Hetil., 2007, 148 , 2202–2203.
Jakab L. , 'The pathophysiological significance of carbohydrate deficient transferrin (In Hungarian) ' (2007 ) 148 Orv. Hetil. : 2202 -2203 .
Cylwik, B., Chrostek, L., Jakimiuk, B. et al.: Serum level of sialic acid (SA) and carbohydrate deficient transferrin (CDT) in type 2 diabetes mellitus with microvascular coomplications. J. Clin. Lab. Anal., 2006, 20 , 68–73.
Jakimiuk B. , 'Serum level of sialic acid (SA) and carbohydrate deficient transferrin (CDT) in type 2 diabetes mellitus with microvascular coomplications ' (2006 ) 20 J. Clin. Lab. Anal. : 68 -73 .
Figlie, N. B., Benedito-Silva, A. A., Monteiro, M. G. et al.: Biological Markers of Alcohol Consumption in Nondrinkers, Drinkers, and Alcohol-Dependent Brazilian Patients. Alcohol Clin. Exp. Res., 2002, 26 , 1062–1069.
Monteiro M. G. , 'Biological Markers of Alcohol Consumption in Nondrinkers, Drinkers, and Alcohol-Dependent Brazilian Patients ' (2002 ) 26 Alcohol Clin. Exp. Res. : 1062 -1069 .
Fleming, M., Mundt, M.: Carbohydrate deficient transferrin: Validity of new alcohol biomarker in a sample of patients with diabetes and hypertension. J. Am. Board Fa. Pract., 2004, 17 , 247–255.
Mundt M. , 'Carbohydrate deficient transferrin: Validity of new alcohol biomarker in a sample of patients with diabetes and hypertension ' (2004 ) 17 J. Am. Board Fa. Pract. : 247 -255 .
Ohtsuka, T., Tsutsumi, N., Fukumura, A. et al.: Use of serum carbohydrate-deficient trransferrin values to exclude alcoholic hepatitis from non-alcoholic steatohepatitis: a pilot study. Alcohol Clin. Exp. Res., 2005, 29 (12 Suppl.) , 236–239.
Fukumura A. , 'Use of serum carbohydrate-deficient trransferrin values to exclude alcoholic hepatitis from non-alcoholic steatohepatitis: a pilot study ' (2005 ) 29 Alcohol Clin. Exp. Res. : 236 -239 .
Steiskal, D., Ruzicka, V., Fanfrdlova, G. et al.: High adiponectin and TNF-alfa levels in moderate drinkers suffering from liver steatosis: comparison with non-drinkers suffering from similar hepatopathy. Biomed. Papers, 2005, 149 , 93–99.
Fanfrdlova G. , 'High adiponectin and TNF-alfa levels in moderate drinkers suffering from liver steatosis: comparison with non-drinkers suffering from similar hepatopathy ' (2005 ) 149 Biomed. Papers : 93 -99 .
Chrostek, L., Cylwik, B., Poplawska, A. et al.: Serum sialic acid and carbohydrate-deficient transferrin concentration in Type 2 diabetes mellitus with and without macrovascular complications. Diabetes Nutr. Metab., 2004, 17 , 371–373.
Poplawska A. , 'Serum sialic acid and carbohydrate-deficient transferrin concentration in Type 2 diabetes mellitus with and without macrovascular complications ' (2004 ) 17 Diabetes Nutr. Metab. : 371 -373 .
Whitfield, J. B., Fletcher, L. M., Murphy, T. M. et al.: Smoking, obesity, and hypertension alter the dose–response curve and test sensitivity of carbohydrate-deficient transferrin as a marker of alcohol intake. Clin. Chem., 1998, 44 , 2480–2489.
Murphy T. M. , 'Smoking, obesity, and hypertension alter the dose–response curve and test sensitivity of carbohydrate-deficient transferrin as a marker of alcohol intake ' (1998 ) 44 Clin. Chem. : 2480 -2489 .
Kaukiainen, A., Vehmas, T., Rantala, K. et al.: Results of common laboratory tests in solvent-exposed workers. Internat. Arch. Occup. Environ. Health, 2004, 77 , 39–46.
Rantala K. , 'Results of common laboratory tests in solvent-exposed workers ' (2004 ) 77 Internat. Arch. Occup. Environ. Health : 39 -46 .
Tompa, A.: Chemical Security and Toxicology. (In Hungarian) Medicina, Budapest, 2005.
Tompa A. , '', in Chemical Security and Toxicology (In Hungarian) , (2005 ) -.